Autologous Hematopoietic Stem Cell Gene Therapy Market Trends And Growth Drivers Point To Strong Future Potential
Autologous Hematopoietic Stem Cell Gene Therapy market size was valued at $6.3 billion in 2026, projected to reach $13.44 billion by 2030 at a 20.8% CAGR. Key players: Novartis, Vertex Pharmaceuticals, CSL Behring
